{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:43:12Z","timestamp":1792698192267,"version":"4.5.0"},"reference-count":113,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atrial fibrillation (AF) is associated with an increased risk of stroke and systemic embolism, and the left atrial appendage (LAA) has been identified as a principal source of thromboembolism in these patients. While oral anticoagulation is the current standard of care, LAA closure (LAAC) emerges as an alternative or complementary treatment approach to reduce the risk of stroke or systemic embolism in patients with AF. Moderate-sized randomized clinical studies have provided data for the efficacy and safety of catheter-based LAAC, largely compared with vitamin K antagonists. LAA device iterations, advances in pre- and peri-procedural imaging, and implantation techniques continue to increase the efficacy and safety of LAAC. More data about efficacy and safety of LAAC have been collected, and several randomized clinical trials are currently underway to compare LAAC with best medical care (including non-vitamin K antagonist oral anticoagulants) in different clinical settings. Surgical LAAC in patients with AF undergoing cardiac surgery reduced the risk of stroke on background of anticoagulation therapy in the LAAOS III study. In this review, we describe the rapidly evolving field of LAAC and discuss recent clinical data, ongoing studies, open questions, and current limitations of LAAC.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehae398","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T09:54:40Z","timestamp":1718877280000},"source":"Crossref","is-referenced-by-count":34,"title":["Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-3203","authenticated-orcid":false,"given":"Ulf","family":"Landmesser","sequence":"first","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charite (DHZC) , Hindenburgdamm 30, 12203 Berlin , Germany"},{"name":"Berlin Institute of Health (BIH) , Anna-Louisa-Karsch-Stra\u00dfe 2, 10178 Berlin , Germany"},{"name":"Friede Springer Cardiovascular Prevention Center@Charit\u00e9 , Hindenburgdamm 30, 12203 Berlin , Germany"},{"name":"DZHK Partner Site Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4953-601X","authenticated-orcid":false,"given":"Carsten","family":"Skurk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charite (DHZC) , Hindenburgdamm 30, 12203 Berlin , Germany"},{"name":"DZHK Partner Site Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6968-2191","authenticated-orcid":false,"given":"Apostolos","family":"Tzikas","sequence":"additional","affiliation":[{"name":"Second Department of Cardiology, Hippocratic University Hospital, Aristotle University of Thessaloniki Department of Cardiology, Interbalkan Medical Center, Pylaia , Thessaloniki , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7911-8620","authenticated-orcid":false,"given":"Volkmar","family":"Falk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charite (DHZC) , Hindenburgdamm 30, 12203 Berlin , Germany"},{"name":"Berlin Institute of Health (BIH) , Anna-Louisa-Karsch-Stra\u00dfe 2, 10178 Berlin , Germany"},{"name":"Friede Springer Cardiovascular Prevention Center@Charit\u00e9 , Hindenburgdamm 30, 12203 Berlin , Germany"},{"name":"DZHK Partner Site Berlin , Germany"},{"name":"Department of Cardiothoracic Surgery, Deutsches Herzzentrum der Charite (DHZC) , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek Y","family":"Reddy","sequence":"additional","affiliation":[{"name":"Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , New York, NY 10029 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2653-6762","authenticated-orcid":false,"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bern University Hospital, Inselspital, University of Bern , Freiburgstrasse 18, 3010 Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"2024071909213964000_ehae398-B1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024071909213964000_ehae398-B2","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart Disease and Stroke Statistics\u20142019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"2024071909213964000_ehae398-B3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"2024071909213964000_ehae398-B4","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-0030-1268861","article-title":"Atrial fibrillation and stroke management: present and future","volume":"30","author":"Holmes","year":"2010","journal-title":"Semin Neurol"},{"key":"2024071909213964000_ehae398-B5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.STR.32.2.392","article-title":"Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (the European Community Stroke Project)","volume":"32","author":"Lamassa","year":"2001","journal-title":"Stroke"},{"key":"2024071909213964000_ehae398-B6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"2024071909213964000_ehae398-B7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2012.04.032","article-title":"Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study","volume":"60","author":"Di Biase","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B8","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.echo.2005.05.006","article-title":"Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: determinants and relationship to spontaneous echocontrast and thrombus formation\u2014a transesophageal echocardiographic study in 500 patients with cerebral ischemia","volume":"18","author":"Handke","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"2024071909213964000_ehae398-B9","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3389\/fphys.2018.01938","article-title":"The impact of left atrium appendage morphology on stroke risk assessment in atrial fibrillation: a computational fluid dynamics study","volume":"9","author":"Masci","year":"2018","journal-title":"Front Physiol"},{"key":"2024071909213964000_ehae398-B10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Writing Committee","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B11","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery","year":"2010","journal-title":"Eur Heart J"},{"key":"2024071909213964000_ehae398-B12","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish atrial fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"2024071909213964000_ehae398-B13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"2024071909213964000_ehae398-B14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2024071909213964000_ehae398-B15","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2024071909213964000_ehae398-B16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"2024071909213964000_ehae398-B17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2024071909213964000_ehae398-B18","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"2024071909213964000_ehae398-B19","doi-asserted-by":"crossref","first-page":"e011471","DOI":"10.1136\/bmjopen-2016-011471","article-title":"Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care","volume":"6","author":"Johnson","year":"2016","journal-title":"BMJ Open"},{"key":"2024071909213964000_ehae398-B20","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2017.07.793","article-title":"Persistence with dabigatran therapy at 2 years in patients with atrial fibrillation","volume":"70","author":"Paquette","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B21","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1093\/eurheartj\/ehu374","article-title":"Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)","volume":"35","author":"Lip","year":"2014","journal-title":"Eur Heart J"},{"key":"2024071909213964000_ehae398-B22","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1093\/eurheartj\/ehw233","article-title":"Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF","volume":"37","author":"Bassand","year":"2016","journal-title":"Eur Heart J"},{"key":"2024071909213964000_ehae398-B23","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.4244\/EIJY14M09_18","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion","volume":"10","author":"Meier","year":"2015","journal-title":"EuroIntervention"},{"key":"2024071909213964000_ehae398-B24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1160\/TH15-04-0350","article-title":"Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study","volume":"115","author":"Martinez","year":"2016","journal-title":"Thromb Haemost"},{"key":"2024071909213964000_ehae398-B25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(15)60245-8","article-title":"Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs","volume":"386","author":"Verheugt","year":"2015","journal-title":"Lancet"},{"key":"2024071909213964000_ehae398-B26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jacep.2023.10.012","article-title":"Severity of ischemic stroke after left atrial appendage closure vs nonwarfarin oral anticoagulants","volume":"10","author":"Turagam","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2024071909213964000_ehae398-B27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"2024071909213964000_ehae398-B28","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1001\/jama.2018.6024","article-title":"Association of surgical left atrial appendage occlusion with subsequent stroke and mortality among patients undergoing cardiac surgery","volume":"319","author":"Yao","year":"2018","journal-title":"JAMA"},{"key":"2024071909213964000_ehae398-B29","doi-asserted-by":"crossref","first-page":"e003074","DOI":"10.1161\/JAHA.115.003074","article-title":"Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation","volume":"5","author":"Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2024071909213964000_ehae398-B30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ahj.2013.12.014","article-title":"Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry","volume":"167","author":"O'Brien","year":"2014","journal-title":"Am Heart J"},{"key":"2024071909213964000_ehae398-B31","first-page":"869","article-title":"Left atrial appendage occlusion: rationale, evidence, devices, and patient selection","volume":"38","author":"Piccini","year":"2017","journal-title":"Eur Heart J"},{"key":"2024071909213964000_ehae398-B32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0735-1097(00)00765-8","article-title":"Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiographic study","volume":"36","author":"Katz","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/jocs.12055","article-title":"Surgical strategies and devices for surgical exclusion of the left atrial appendage: a word of caution","volume":"28","author":"Apostolakis","year":"2013","journal-title":"J Card Surg"},{"key":"2024071909213964000_ehae398-B34","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jacc.2008.03.067","article-title":"Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography","volume":"52","author":"Kanderian","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jtcvs.2007.08.057","article-title":"Simplified technique for surgical ligation of the left atrial appendage in high-risk patients","volume":"135","author":"Bakhtiary","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024071909213964000_ehae398-B36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.116.021952","article-title":"Impact of left atrial appendage closure during cardiac surgery on the occurrence of early postoperative atrial fibrillation, stroke, and mortality: a propensity score-matched analysis of 10 633 patients","volume":"135","author":"Melduni","year":"2017","journal-title":"Circulation"},{"key":"2024071909213964000_ehae398-B37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/15569845221123796","article-title":"Prophylactic left atrial appendage exclusion in cardiac surgery patients with elevated CHA(2)DS(2)-VASc score: results of the randomized ATLAS trial","volume":"17","author":"Gerdisch","year":"2022","journal-title":"Innovations (Phila)"},{"key":"2024071909213964000_ehae398-B38","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"key":"2024071909213964000_ehae398-B39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.2017.20125","article-title":"Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing concomitant cardiac surgery","volume":"319","author":"Friedman","year":"2018","journal-title":"JAMA"},{"key":"2024071909213964000_ehae398-B40","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"2024071909213964000_ehae398-B41","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jacc.2015.03.593","article-title":"Left atrial appendage closure to reduce the risk of thromboembolic complications in atrial fibrillation: pay now and possibly pay later?","volume":"65","author":"Waks","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.amjcard.2014.11.011","article-title":"Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy","volume":"115","author":"Waksman","year":"2015","journal-title":"Am J Cardiol"},{"key":"2024071909213964000_ehae398-B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B44","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B45","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"Left atrial appendage closure versus non-warfarin oral anticoagulation in atrial fibrillation: 4-year outcomes of PRAGUE-17","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"2024071909213964000_ehae398-B48","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1016\/j.jacc.2022.01.056","article-title":"Primary composite outcome in PRAGUE-17: an unintended butterfly effect","volume":"79","author":"Kim","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B49","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.jacc.2020.08.089","article-title":"Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: a meta-analysis of randomized trials","volume":"76","author":"Turagam","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B50","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer Amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (Amulet IDE): a randomized controlled trial","volume":"144:","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"2024071909213964000_ehae398-B51","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jcin.2023.06.022","article-title":"3-year outcomes from the Amplatzer Amulet left atrial appendage occluder randomized controlled trial (Amulet IDE)","volume":"16","author":"Lakkireddy","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B52","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"2024071909213964000_ehae398-B53","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.4244\/EIJ-D-18-00344","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry","volume":"14","author":"Landmesser","year":"2018","journal-title":"EuroIntervention"},{"key":"2024071909213964000_ehae398-B54","doi-asserted-by":"crossref","first-page":"e942","DOI":"10.4244\/EIJ-D-19-01027","article-title":"WATCHMAN versus ACP or Amulet devices for left atrial appendage occlusion: a sub-analysis of the multicentre LAARGE registry","volume":"16","author":"Ledwoch","year":"2020","journal-title":"EuroIntervention"},{"key":"2024071909213964000_ehae398-B55","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.3390\/jcm12144573","article-title":"Safety and healthcare resource utilization in patients undergoing left atrial appendage closure \u2013 a nationwide analysis","volume":"12","author":"Thevathasan","year":"2023","journal-title":"J Clin Med"},{"key":"2024071909213964000_ehae398-B56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.hrthm.2019.09.018","article-title":"Incidence and causes of in-hospital outcomes and 30-day readmissions after percutaneous left atrial appendage closure: a US nationwide retrospective cohort study using claims data","volume":"17","author":"Vuddanda","year":"2020","journal-title":"Heart Rhythm"},{"key":"2024071909213964000_ehae398-B57","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jcin.2020.11.029","article-title":"Association of hospital procedural volume with outcomes of percutaneous left atrial appendage occlusion","volume":"14","author":"Nazir","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B58","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"key":"2024071909213964000_ehae398-B59","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jacep.2023.04.013","article-title":"Enhanced thromboresistance and endothelialization of a novel fluoropolymer-coated left atrial appendage closure device","volume":"9","author":"Saliba","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2024071909213964000_ehae398-B60","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jcin.2021.05.016","article-title":"Large LAA\u2014too big for closure?: LAA closure with the world\u2019s biggest percutaneous closure device","volume":"14","author":"Skurk","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B61","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jcin.2018.05.023","article-title":"Percutaneous left atrial appendage closure with the Ultraseal device: insights from the initial multicenter experience","volume":"11","author":"Asmarats","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B62","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.4244\/EIJ-D-20-00552","article-title":"First-in-human results of the Omega left atrial appendage occluder for patients with non-valvular atrial fibrillation","volume":"17","author":"Wilkins","year":"2021","journal-title":"EuroIntervention"},{"key":"2024071909213964000_ehae398-B63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/joic.12502","article-title":"An updated systematic review and meta-analysis of early outcomes after left atrial appendage occlusion","volume":"31","author":"Yerasi","year":"2018","journal-title":"J Interv Cardiol"},{"key":"2024071909213964000_ehae398-B64","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.hrthm.2015.12.037","article-title":"Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials and observational studies","volume":"13","author":"Li","year":"2016","journal-title":"Heart Rhythm"},{"key":"2024071909213964000_ehae398-B65","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jcin.2013.11.010","article-title":"Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies","volume":"7","author":"Bajaj","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/heartjnl-2016-309782","article-title":"Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials","volume":"103","author":"Sahay","year":"2017","journal-title":"Heart"},{"key":"2024071909213964000_ehae398-B67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B68","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jama.2017.1371","article-title":"Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation","volume":"317","author":"Xian","year":"2017","journal-title":"JAMA"},{"key":"2024071909213964000_ehae398-B69","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.25700","article-title":"Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation","volume":"87","author":"Seiffge","year":"2020","journal-title":"Ann Neurol"},{"key":"2024071909213964000_ehae398-B70","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/CIRCULATIONAHA.122.061132","article-title":"What is the future of factor XI inhibitors?","volume":"146","author":"Weitz","year":"2022","journal-title":"Circulation"},{"key":"2024071909213964000_ehae398-B71","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(22)00456-1","article-title":"Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study","volume":"399","author":"Piccini","year":"2022","journal-title":"Lancet"},{"key":"2024071909213964000_ehae398-B72","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1540-8167.2012.02360.x","article-title":"Incomplete endothelialization of left atrial appendage occlusion device 10 months after implantation","volume":"23","author":"Massarenti","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2024071909213964000_ehae398-B73","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1038\/s41598-021-82359-1","article-title":"Preclinical assessment of a modified Occlutech left atrial appendage closure device in a porcine model","volume":"11","author":"Reinthaler","year":"2021","journal-title":"Sci Rep"},{"key":"2024071909213964000_ehae398-B74","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jcin.2014.03.003","article-title":"Impact of Watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model","volume":"7","author":"Kar","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcin.2020.10.034","article-title":"Peridevice leak following Amplatzer left atrial appendage occlusion: cardiac computed tomography classification and clinical outcomes","volume":"14","author":"Korsholm","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B76","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4244\/EIJ-D-16-00726","article-title":"Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy","volume":"12","author":"Korsholm","year":"2017","journal-title":"EuroIntervention"},{"key":"2024071909213964000_ehae398-B77","doi-asserted-by":"crossref","first-page":"E111","DOI":"10.1002\/ccd.26903","article-title":"Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer cardiac plug and the Amulet","volume":"90","author":"Lempereur","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B78","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-Related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B79","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"key":"2024071909213964000_ehae398-B80","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjcard.2016.01.039","article-title":"Assessment of device-related thrombus and associated clinical outcomes with the WATCHMAN left atrial appendage closure device for embolic protection in patients with atrial fibrillation (from the PROTECT-AF trial)","volume":"117","author":"Main","year":"2016","journal-title":"Am J Cardiol"},{"key":"2024071909213964000_ehae398-B81","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation"},{"key":"2024071909213964000_ehae398-B82","doi-asserted-by":"crossref","first-page":"E1019","DOI":"10.1002\/ccd.29458","article-title":"Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device\u2014insights from the EWOLUTION real world registry","volume":"97","author":"Sedaghat","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B83","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jacc.2010.09.049","article-title":"Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation","volume":"57","author":"Daccarett","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B84","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur Heart J"},{"key":"2024071909213964000_ehae398-B85","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B86","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jcin.2019.04.004","article-title":"Propensity-matched comparison of oral anticoagulation versus antiplatelet therapy after left atrial appendage closure with WATCHMAN","volume":"12","author":"Sondergaard","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B87","doi-asserted-by":"crossref","first-page":"e010195","DOI":"10.1161\/CIRCINTERVENTIONS.120.010195","article-title":"Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-registry","volume":"14","author":"Sedaghat","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B88","doi-asserted-by":"crossref","first-page":"e008481","DOI":"10.1161\/CIRCINTERVENTIONS.119.008481","article-title":"Reduced rivaroxaban dose versus dual antiplatelet therapy after left atrial appendage closure: ADRIFT a randomized pilot study","volume":"13","author":"Duthoit","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B89","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B90","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","article-title":"The clinical impact of incomplete left atrial appendage closure with the Watchman device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation) substudy","volume":"59","author":"Viles-Gonzalez","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B91","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jcin.2022.09.001","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion: an analysis of the Amulet IDE trial","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B92","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jcin.2022.12.006","article-title":"Peridevice leak after left atrial appendage occlusion: incidence, mechanisms, clinical impact, and management","volume":"16","author":"Alkhouli","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B93","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4244\/EIJV15I8A119","article-title":"Comparison of cardiac computed tomography angiography and transoesophageal echocardiography for device surveillance after left atrial appendage closure. What we see depends on where we are looking from and what we are looking for","volume":"15","author":"Holmes","year":"2019","journal-title":"EuroIntervention"},{"key":"2024071909213964000_ehae398-B94","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4244\/EIJ-D-18-01107","article-title":"Comparison of cardiac computed tomography angiography and transoesophageal echocardiography for device surveillance after left atrial appendage closure","volume":"15","author":"Qamar","year":"2019","journal-title":"EuroIntervention"},{"key":"2024071909213964000_ehae398-B95","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/eurheartj\/ehad828","article-title":"Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis","volume":"45","author":"Samaras","year":"2024","journal-title":"Eur Heart J"},{"key":"2024071909213964000_ehae398-B96","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/ehjci\/jev067","article-title":"Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure","volume":"16","author":"Saw","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2024071909213964000_ehae398-B97","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ehjci\/jey010","article-title":"Left atrial appendage patency and device-related thrombus after percutaneous left atrial appendage occlusion: a computed tomography study","volume":"19","author":"Cochet","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2024071909213964000_ehae398-B98","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ccd.25667","article-title":"Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device","volume":"85","author":"Jaguszewski","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B99","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jacep.2015.08.006","article-title":"Left atrial appendage eccentricity and irregularity are associated with residual leaks after percutaneous closure","volume":"1","author":"Rajwani","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"2024071909213964000_ehae398-B100","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2024071909213964000_ehae398-B101","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2022.04.062","article-title":"Impact of peridevice leak on 5-year outcomes after left atrial appendage closure","volume":"80","author":"Dukkipati","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024071909213964000_ehae398-B102","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcin.2023.01.008","article-title":"Impact of computational modeling on transcatheter left atrial appendage closure efficiency and outcomes","volume":"16","author":"De Backer","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B103","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jcin.2022.10.024","article-title":"Intracardiac echocardiography to guide Watchman FLX implantation: the ICE LAA study","volume":"16","author":"Nielsen-Kudsk","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B104","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jcin.2019.10.022","article-title":"First experience of transcatheter leak occlusion with detachable coils following left atrial appendage closure","volume":"13","author":"Della Rocca","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B105","doi-asserted-by":"crossref","first-page":"e1033","DOI":"10.4244\/EIJ-D-21-00286","article-title":"Safety and feasibility of peri-device leakage closure after LAAO: an international, multi-center collaborative study","volume":"17:","author":"Piayda","year":"2021","journal-title":"EuroIntervention"},{"key":"2024071909213964000_ehae398-B106","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacep.2021.06.002","article-title":"Radiofrequency energy applications targeting significant residual leaks after Watchman implantation: a prospective, multicenter experience","volume":"7","author":"Della Rocca","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2024071909213964000_ehae398-B107","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.jcin.2022.08.034","article-title":"Evaluation of multimodality LAA leak closure methods following incomplete occlusion: the LAA leak study","volume":"15","author":"Charate","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2024071909213964000_ehae398-B108","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.hrthm.2022.01.007","article-title":"Frailty in patients undergoing percutaneous left atrial appendage closure","volume":"19","author":"Wang","year":"2022","journal-title":"Heart Rhythm"},{"key":"2024071909213964000_ehae398-B109","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/pace.14649","article-title":"Comparative performance of distinct frailty measures among patients undergoing percutaneous left atrial appendage closure","volume":"46","author":"Wang","year":"2023","journal-title":"Pacing Clin Electrophysiol"},{"key":"2024071909213964000_ehae398-B110","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/heartjnl-2020-317741","article-title":"Comorbidity burden in patients undergoing left atrial appendage closure","volume":"107","author":"Sanjoy","year":"2021","journal-title":"Heart"},{"key":"2024071909213964000_ehae398-B111","doi-asserted-by":"crossref","first-page":"e021973","DOI":"10.1161\/JAHA.121.021973","article-title":"Outcomes of elderly patients undergoing left atrial appendage closure","volume":"10","author":"Sanjoy","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2024071909213964000_ehae398-B112","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.amjcard.2020.09.017","article-title":"Comparison in patients &lt;75 years of age-versus-those &gt;75 years on one-year-events with atrial fibrillation and left atrial appendage occluder (from the prospective multicenter German LAARGE registry)","volume":"136","author":"Nasasra","year":"2020","journal-title":"Am J Cardiol"},{"key":"2024071909213964000_ehae398-B113","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacep.2022.06.012","article-title":"Incidence and predictors of early death in patients undergoing percutaneous left atrial appendage closure","volume":"8","author":"Mesnier","year":"2022","journal-title":"JACC Clin Electrophysiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehae398\/58594715\/ehae398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehae398\/58594715\/ehae398.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T05:22:36Z","timestamp":1721366556000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehae398\/7716876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":113,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehae398","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"article-number":"ehae398"}}